Healthcare >> CEO Interviews >> January 26, 2004
ROBERT W. RIEDER has been a Director of Cardiome Pharma Corp. since
April 1997, and the President and Chief Executive Officer of the company
since April 1998. Mr. Rieder has extensive experience in venture capital
and in operational management. Before joining Cardiome, he was Vice
President at MDS Ventures Pacific Inc., the Vancouver-based affiliate of
MDS Capital Corp., Canada's largest medical investment fund. Mr. Rieder
also formerly held the position of Chief Operating Officer for DBA
Telecom Inc. and acting CEO of Synapse Technologies Inc. Mr. Rieder
currently serves as a Director of Micrologix Biotech Inc. and Synapse
Technologies Inc. Mr. Rieder holds an undergraduate degree in Chemical
Engineering from UBC and an MBA from the University of Western Ontario. Profile
current focus of your research?
Mr. Rieder: Our company is focused on becoming a leader in
cardiovascular drug development.
